Cargando…
Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder
INTRODUCTION: Cannabis use disorder (CUD) is prevalent in ~2–5% of adults in the United States and is anticipated to increase as restrictions to cannabis decrease and tetrahydrocannabinol (THC) content in cannabis products increase. No FDA-approved medications for CUD are currently available, despit...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10330760/ https://www.ncbi.nlm.nih.gov/pubmed/37435402 http://dx.doi.org/10.3389/fpsyt.2023.1144276 |